AI-assisted heart function check for atrial fibrillation management
Part of Heart & circulation clinical trials.
This study uses an artificial intelligence (AI) tool to read your heart's electrical activity (ECG) to help doctors better manage your atrial fibrillation (AFib), an irregular heartbeat that can increase stroke risk. By combining the ECG with a heart ultrasound (echocardiogram), the AI aims to improve treatment decisions and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have atrial fibrillation (an irregular heartbeat) confirmed by an ECG within the last 12 months.
- Your doctor must have recommended an echocardiogram (an ultrasound of your heart).
- Your stroke risk score (called CHA₂DS₂-VA) must be 2 or higher. This is based on things like age, high blood pressure, diabetes, and previous stroke.
- You must be 19 years or older and willing to give written consent.
- You cannot have had an echocardiogram in the last 6 months, have severe heart disease or heart surgery, or have certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.
This study tests whether artificial intelligence (AI) can analyze heart signals from a standard 12-lead ECG and a simpler 1-lead ECG. Participants will have an extra ECG taken during their regular visit, which takes just a few extra minutes and helps doctors learn if AI can spot heart issues from a simpler test.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This study uses special heart tests (AI-ECG and CT scan) to look for a hidden condition called cardiac amyloidosis, which can affect people with atrial fibrillation. Finding it early may help guide treatment and improve outcomes.
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.